SCHEMBL5907367

SCHEMBL5907367

Fc1ccccc1-c1c(CN2CCOCC2)cnn1-c1ccc(-c2cc(Cl)cc(Cl)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 4/20 0.44
SLC2A1 P11166 2/20 0.42
SSTR5 P35346 1/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.39
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
JAK2 O60674 2/20 0.38
JAK1 P23458 2/20 0.38
TYK2 P29597 2/20 0.38
JAK3 P52333 2/20 0.38
CYP1A2 P05177 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3R2 O00459 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730763 0.93 KMT2A (0.46) CYP2A13SLC2A1SSTR5CYP2C19ALDH1A1
SCHEMBL5732371 0.93 SLC2A1 (0.45) CYP2A13SLC2A1SSTR5CYP2C19CYP3A4
SCHEMBL5730793 0.90 CYP2A13 (0.45) CYP2A13SLC2A1SSTR5CYP2C19CYP3A4
SCHEMBL5907325 0.90 CYP2A13 (0.45) CYP2A13SLC2A1SSTR5CYP2C19CYP3A4
SCHEMBL5907306 0.90 CYP2A13 (0.45) CYP2A13SLC2A1SSTR5CYP2C19CYP3A4
SCHEMBL5907238 0.89 CYP2A13 (0.50) CYP2A13SSTR5CYP2C19CYP3A4CYP2D6
SCHEMBL5907262 0.88 CYP2A13 (0.45) CYP2A13SLC2A1SSTR5CYP3A4CYP2D6
SCHEMBL5907335 0.88 CYP2A13 (0.47) CYP2A13SSTR5ALDH1A1KMT2AADORA2A
SCHEMBL5907245 0.87 CYP2A13 (0.44) CYP2A13SLC2A1SSTR5ALDH1A1KMT2A
SCHEMBL5731706 0.87 CYP2A13 (0.46) CYP2A13SLC2A1SSTR5ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264419-A1 Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264419-A1 Substituted pyrazoles HTR3A, HTR1A, HTR1D CYP2A13 659/4885SLC2A1 1980/4885SSTR5 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.